Form D — ASCENDIA PHARMACEUTICALS, INC.
0001855888-25-000001 · filed 2025-06-04
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $2,500,000
- Total sold
- $2,500,000
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ASCENDIA PHARMACEUTICALS, INC.
- CIK
- 1855888
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 661 US HIGHWAY ONE
NEW BRUNSWICK, NJ 08902 - Phone
- 732-640-0058
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jingjun Huang · Executive OfficerNew Brunswick, NJ Find on LinkedIn ↗
-
Robert Bloder · DirectorNew Brunswick, NJ Find on LinkedIn ↗
-
Shoufeng Li · DirectorNew Brunswick, NJ Find on LinkedIn ↗
-
James Gale · DirectorNew Brunswick, NJ Find on LinkedIn ↗
-
Theron Odlaug · DirectorNew Brunswick, NJ Find on LinkedIn ↗
View original on SEC EDGAR.